Mark R.  Ziebell net worth and biography

Mark Ziebell Biography and Net Worth

General Counsel of Avid Bioservices
Mark Ziebell has served as Vice President and General Counsel since June 2012. Prior to joining the organization, Mr. Ziebell was a Partner at Snell & Wilmer LLP, a law firm based in Orange County, California where his practice specialized in securities law, mergers and acquisitions, corporate governance and general corporate law representing companies in a broad range of industries including the biopharmaceutical and technology sectors. Prior to Snell & Wilmer, he was a Partner at the law firm of Falk, Shaff & Ziebell where he was part of the Corporate and Securities practice area. Prior to that Mr. Ziebell has held positions of increasing responsibility within the accounting and legal sectors.

Mr. Ziebell holds a JD degree from the University of San Francisco, School of Law and a BA in Accounting from the University of San Francisco.

What is Mark R. Ziebell's net worth?

The estimated net worth of Mark R. Ziebell is at least $801,348.24 as of April 30th, 2024. Mr. Ziebell owns 64,834 shares of Avid Bioservices stock worth more than $801,348 as of December 18th. This net worth estimate does not reflect any other investments that Mr. Ziebell may own. Additionally, Mr. Ziebell receives a salary of $477,160.00 as General Counsel at Avid Bioservices. Learn More about Mark R. Ziebell's net worth.

How old is Mark R. Ziebell?

Mr. Ziebell is currently 60 years old. There are 4 older executives and no younger executives at Avid Bioservices. Learn More on Mark R. Ziebell's age.

What is Mark R. Ziebell's salary?

As the General Counsel of Avid Bioservices, Inc., Mr. Ziebell earns $477,160.00 per year. There are 2 executives that earn more than Mr. Ziebell. The highest earning executive at Avid Bioservices is Mr. Nicholas Stewart Green B.Sc., MBA, President, CEO & Director, who commands a salary of $699,010.00 per year. Learn More on Mark R. Ziebell's salary.

How do I contact Mark R. Ziebell?

The corporate mailing address for Mr. Ziebell and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected]. Learn More on Mark R. Ziebell's contact information.

Has Mark R. Ziebell been buying or selling shares of Avid Bioservices?

Mark R. Ziebell has not been actively trading shares of Avid Bioservices during the past quarter. Most recently, Mark R. Ziebell sold 1,643 shares of the business's stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $7.40, for a transaction totalling $12,158.20. Following the completion of the sale, the general counsel now directly owns 64,834 shares of the company's stock, valued at $479,771.60. Learn More on Mark R. Ziebell's trading history.

Who are Avid Bioservices' active insiders?

Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.

Are insiders buying or selling shares of Avid Bioservices?

In the last twelve months, insiders at the biopharmaceutical company sold shares 15 times. They sold a total of 50,858 shares worth more than $423,264.89. The most recent insider tranaction occured on October, 14th when insider Matthew R Kwietniak sold 119 shares worth more than $1,207.85. Insiders at Avid Bioservices own 3.1% of the company. Learn More about insider trades at Avid Bioservices.

Information on this page was last updated on 10/14/2024.

Mark R. Ziebell Insider Trading History at Avid Bioservices

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2024Sell1,643$7.40$12,158.2064,834View SEC Filing Icon  
1/10/2024Sell1,346$6.17$8,304.8263,269View SEC Filing Icon  
10/10/2023Sell1,141$9.20$10,497.2060,515View SEC Filing Icon  
7/10/2023Sell687$13.77$9,459.9949,173View SEC Filing Icon  
6/29/2023Sell2,377$12.70$30,187.9048,255View SEC Filing Icon  
5/1/2023Sell25,000$17.91$447,750.0040,119View SEC Filing Icon  
4/10/2023Sell736$19.80$14,572.8040,119View SEC Filing Icon  
1/10/2023Sell1,150$14.44$16,606.0038,897View SEC Filing Icon  
4/11/2022Sell368$18.56$6,830.088,103View SEC Filing Icon  
3/21/2022Sell1,974$22.03$43,487.22View SEC Filing Icon  
3/18/2022Sell1,302$22.01$28,657.02View SEC Filing Icon  
2/10/2022Sell6,429$22.14$142,338.06View SEC Filing Icon  
1/10/2022Sell351$21.58$7,574.58View SEC Filing Icon  
1/3/2022Sell20,675$27.65$571,663.75View SEC Filing Icon  
12/27/2021Sell6,829$30.27$206,713.83View SEC Filing Icon  
12/15/2021Sell6,429$24.57$157,960.53View SEC Filing Icon  
10/11/2021Sell349$22.37$7,807.13View SEC Filing Icon  
7/12/2021Sell7,207$25.61$184,571.27View SEC Filing Icon  
7/13/2020Sell3,683$6.88$25,339.0410,512View SEC Filing Icon  
See Full Table

Mark R. Ziebell Buying and Selling Activity at Avid Bioservices

This chart shows Mark R Ziebell's buying and selling at Avid Bioservices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avid Bioservices Company Overview

Avid Bioservices logo
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
Read More

Today's Range

Now: $12.36
Low: $12.33
High: $12.38

50 Day Range

MA: $11.42
Low: $9.96
High: $12.36

2 Week Range

Now: $12.36
Low: $5.65
High: $12.48

Volume

640,560 shs

Average Volume

1,320,362 shs

Market Capitalization

$790.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44